2022
DOI: 10.1002/lary.30516
|View full text |Cite
|
Sign up to set email alerts
|

Joint Vestibular Schwannoma Enlargement Prediction and Segmentation Using a Deep Multi‐task Model

Abstract: ObjectiveTo develop a deep‐learning‐based multi‐task (DMT) model for joint tumor enlargement prediction (TEP) and automatic tumor segmentation (TS) for vestibular schwannoma (VS) patients using their initial diagnostic contrast‐enhanced T1‐weighted (ceT1) magnetic resonance images (MRIs).MethodsInitial ceT1 MRIs for VS patients meeting the inclusion/exclusion criteria of this study were retrospectively collected. VSs on the initial MRIs and their first follow‐up scans were manually contoured. Tumor volume and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…The current work describes a stratification grouping whereby a certain subset of patients can almost be assured of future tumor growth (those with a volumetric growth rate of ≥100% per year), whereas those with a volumetric growth rate less than 25% per year demonstrate more saltatory growth patterns with a greater likelihood of long-term quiescence. Consideration for use of a classification schema that accounts for the dynamic biological behavior of these tumors is warranted during wait-and-scan management (17), and the stratification grouping described in the current work may provide this clinical utility as volumetric measurements become increasingly common clinically (22). Moreover, these data further illustrate that some degree of tumor growth should be expected for all patients with sporadic vestibular schwannoma during wait-and-scan management—even among the slowest-growing subset of tumors, nearly 70% displayed additional growth within 5 years of the first episode of growth.…”
Section: Discussionmentioning
confidence: 99%
“…The current work describes a stratification grouping whereby a certain subset of patients can almost be assured of future tumor growth (those with a volumetric growth rate of ≥100% per year), whereas those with a volumetric growth rate less than 25% per year demonstrate more saltatory growth patterns with a greater likelihood of long-term quiescence. Consideration for use of a classification schema that accounts for the dynamic biological behavior of these tumors is warranted during wait-and-scan management (17), and the stratification grouping described in the current work may provide this clinical utility as volumetric measurements become increasingly common clinically (22). Moreover, these data further illustrate that some degree of tumor growth should be expected for all patients with sporadic vestibular schwannoma during wait-and-scan management—even among the slowest-growing subset of tumors, nearly 70% displayed additional growth within 5 years of the first episode of growth.…”
Section: Discussionmentioning
confidence: 99%
“…Predictive models could be used to guide management decisions for VS by providing clinicians and patients with quantitative estimates of risk. For example, predictive models have been developed to predict VS growth, 18,19 VS recurrence following surgery, 20,21 and VS treatment response following radiation treatment. 22,23 In our study, the binary classification model could provide a probabilistic estimate of having vestibular dysfunction at the 3-, 6-, or 12-month marks; and the 4-way classification model would provide individual probabilities for each of these time points.…”
Section: Discussionmentioning
confidence: 99%
“…AI-assisted radiomics can be extremely useful in the follow-up of specific diseases, such as vestibular schwannoma, whose surveillance is nowadays performed through analogical segmentation and an analysis of serial MRI scans to detect tumor enlargement. A deep learning approach can be applied for tumor detection and segmentation in treatment-naïve patients [120], both after radiosurgery [121], in evaluating residual disease [122], and in predicting tumor enlargement based on radiomics parameters during follow-up [123].…”
Section: Imaging In Otologymentioning
confidence: 99%